• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Cross Country Healthcare Inc.

    12/4/24 4:50:40 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary
    Get the next $CCRN alert in real time by email
    DEFA14A 1 dp221646_defa14a-5investor.htm FORM DEFA14A

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 14A

    PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

     

     

    Filed by the Registrant ☒

     

    Filed by a Party other than the Registrant ☐

     

    Check the appropriate box:

     

    ☐ Preliminary Proxy Statement

     

    ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ☐ Definitive Proxy Statement

     

    ☐ Definitive Additional Materials

     

    ☒ Soliciting Material Pursuant to § 240.14a-12

     

    CROSS COUNTRY HEALTHCARE, INC.

    (Name of Registrant as Specified In Its Charter)

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check all boxes that apply):

     

    ☒ No fee required.

     

    ☐ Fee paid previously with preliminary materials.

     

    ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     

     

    The following email was sent by Josh Vogel, Vice President of Investor Relations of Cross Country Healthcare, Inc. (“Cross Country”), to its investors and analysts on December 4, 2024 in connection with the proposed acquisition of Cross Country by Aya Healthcare, Inc.

     

     

     

    Good morning,

    Cross Country Healthcare has just announced that it has entered into a definitive agreement to be acquired by Aya Healthcare. The all-cash transaction represents a premium of 67% to Cross Country’s closing price on December 3rd and a premium of 68% to the volume-weighted average trading price for the 30-day trading period ended December 3rd. You can read the press release on the Investor Relations page of our website at https://ir.crosscountryhealthcare.com/press-releases.

    Completion of the transaction is expected in the first half of 2025, subject to the approval of Cross Country stockholders and the satisfaction of other customary closing conditions, including regulatory approvals.

     

    If you would like to schedule a call to discuss the news, please let me know.

     

    Thank you,
    Josh Vogel

     

    Vice President, Investor Relations

     

    Important Information and Where to Find It

     

    This communication relates to a proposed transaction between Cross Country Healthcare, Inc. (“Cross Country”) and Aya Healthcare, Inc. (“Aya”) and certain wholly owned subsidiaries of Aya. In connection with this proposed transaction, Cross Country will file a proxy statement on Schedule 14A or other documents with the SEC. This communication is not a substitute for any proxy statement or other document that Cross Country may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF CROSS COUNTRY ARE URGED TO READ THE PROXY STATEMENT, INCLUDING THE DOCUMENTS INCORPORATED BY REFERENCE INTO THE PROXY STATEMENT, AND OTHER DOCUMENTS THAT MAY BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. The definitive proxy statement, when available, will be mailed to stockholders of Cross Country as applicable. Investors and security holders will be able to obtain free copies of these documents, when available, and other documents filed with the SEC by Cross Country through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Cross Country will be available free of charge on Cross Country’s internet website at https://ir.crosscountryhealthcare.com/ or by contacting Cross Country’s primary investor relations contact by email at [email protected] or by phone at 561-237-8310.

     

    Cross Country Healthcare, Inc. 

    6551 Park of Commerce Blvd., Boca Raton, FL 33487 

    (800) 347.2264 | crosscountry.com

     

    Participants in the Solicitation

     

    Cross Country, Aya, their respective directors and certain of their respective executive officers may be considered participants in the solicitation of proxies in connection with the proposed transaction. Information about the directors and executive officers of Cross Country, their ownership of Cross Country common shares, and Cross Country’s transactions with related persons is set forth in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, which was filed with the SEC on February 23, 2024 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/1141103/000162828024006454/ccrn-20231231.htm), in its proxy statement on Schedule 14A for its 2024 Annual Meeting of Stockholders in the sections entitled “Security Ownership of Certain Beneficial Owners and Management” and “Related Party Transactions”, which was filed with the SEC on April 1, 2024 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/1141103/000114036124016761/ny20018339x1_def14a.htm), certain of its Quarterly Reports on Form 10-Q and certain of its Current Reports on Form 8-K.

     

    These documents can be obtained free of charge from the sources indicated above. Additional information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC when they become available.

     

    No Offer or Solicitation

     

    This communication is for informational purposes only and is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

     

    Cross Country Healthcare, Inc. 

    6551 Park of Commerce Blvd., Boca Raton, FL 33487 

    (800) 347.2264 | crosscountry.com

     

    Cautionary Note Regarding Forward-Looking Statements

     

    This communication contains “forward-looking statements” within the Private Securities Litigation Reform Act of 1995. Any statements contained in this communication that are not statements of historical fact, including statements regarding the proposed transaction, including the expected timing and closing of the proposed transaction; Cross Country’s ability to consummate the proposed transaction; the expected benefits of the proposed transaction and other considerations taken into account by the Cross Country Board of Directors in approving the proposed transaction; the amounts to be received by stockholders and expectations for Cross Country prior to and following the closing of the proposed transaction, may be deemed to be forward-looking statements. All such forward-looking statements are intended to provide management’s current expectations for the future of Cross Country based on current expectations and assumptions relating to Cross Country’s business, the economy and other future conditions. Forward-looking statements generally can be identified through the use of words such as “believes,” “anticipates,” “may,” “should,” “will,” “plans,” “projects,” “expects,” “expectations,” “estimates,” “forecasts,” “predicts,” “targets,” “prospects,” “strategy,” “signs,” and other words of similar meaning in connection with the discussion of future performance, plans, actions or events. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict. Such risks and uncertainties include, among others: (i) the timing to consummate the proposed transaction, (ii) the risk that a condition of closing of the proposed transaction may not be satisfied or that the closing of the proposed transaction might otherwise not occur, (iii) the risk that a regulatory approval that may be required for the proposed transaction is not obtained or is obtained subject to conditions that are not anticipated, (iv) the diversion of management time on transaction-related issues, (v) risks related to disruption of management time from ongoing business operations due to the proposed transaction, (vi) the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of the common stock of Cross Country, (vii) the risk that the proposed transaction and its announcement could have an adverse effect on the ability of Cross Country to retain customers and retain and hire key personnel and maintain relationships with its suppliers and customers, (viii) the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the Merger Agreement, including in circumstances requiring Cross Country to pay a termination fee, (ix) the risk that competing offers will be made, (x) unexpected costs, charges or expenses resulting from the merger, (xi) potential litigation relating to the merger that could be instituted against the parties to the Merger Agreement or their respective directors, managers or officers, including the effects of any outcomes related thereto, (xii) worldwide economic or political changes that affect the markets that Cross Country’s businesses serve which could have an effect on demand for Cross Country’s services and impact Cross Country’s profitability, (xiii) effects from global pandemics, epidemics or other public health crises, (xiv) changes in marketplace conditions, such as alternative modes of healthcare delivery, reimbursement and customer needs and (xv) disruptions in the global credit and financial markets, including diminished liquidity and credit availability, changes in international trade agreements, including tariffs and trade restrictions, cyber-security vulnerabilities, foreign currency volatility, swings in consumer confidence and spending, costs of providing services, retention of key employees, and outcomes of legal proceedings, claims and investigations. Accordingly, actual results may differ materially from those contemplated by these forward-looking statements. Investors, therefore, are cautioned against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in Cross Country’s filings with the SEC, including the risks and uncertainties identified in Part I, Item 1A - Risk Factors of Cross Country’s Annual Report on Form 10-K for the year ended December 31, 2023 and in Cross Country’s other filings with the SEC. The list of factors is not intended to be exhaustive.

     

    Cross Country Healthcare, Inc. 

    6551 Park of Commerce Blvd., Boca Raton, FL 33487 

    (800) 347.2264 | crosscountry.com

     

    These forward-looking statements speak only as of the date of this communication, and Cross Country does not assume any obligation to update or revise any forward-looking statement made in this communication or that may from time to time be made by or on behalf of Cross Country.

     

    Cross Country Healthcare, Inc. 

    6551 Park of Commerce Blvd., Boca Raton, FL 33487 

    (800) 347.2264 | crosscountry.com

     

     

     

    Get the next $CCRN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CCRN

    DatePrice TargetRatingAnalyst
    3/5/2026$14.00Hold → Buy
    The Benchmark Company
    2/3/2026$11.00Neutral
    Wedbush
    12/4/2025$11.00Mkt Perform → Mkt Outperform
    Citizens JMP
    12/10/2024Outperform → Mkt Perform
    Barrington Research
    12/6/2023Mkt Perform
    JMP Securities
    11/3/2023$32.00 → $21.00Buy → Hold
    Jefferies
    6/26/2023Outperform
    William Blair
    3/10/2023$30.00Buy
    Loop Capital
    More analyst ratings

    $CCRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Hawkins Amiee Lin claimed ownership of 29,273 shares (SEC Form 3)

    3 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

    2/18/26 5:05:32 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Amendment: General Counsel and Secretary Ball Susan E covered exercise/tax liability with 9,386 shares, decreasing direct ownership by 5% to 176,032 units (SEC Form 4)

    4/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

    1/12/26 10:43:34 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Director Nevin Janice Elizabeth was granted 18,680 shares, increasing direct ownership by 62% to 48,616 units (SEC Form 4)

    4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

    12/22/25 7:24:05 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cross Country upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Cross Country from Hold to Buy and set a new price target of $14.00

    3/5/26 8:22:11 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Wedbush initiated coverage on Cross Country with a new price target

    Wedbush initiated coverage of Cross Country with a rating of Neutral and set a new price target of $11.00

    2/3/26 8:08:13 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Cross Country from Mkt Perform to Mkt Outperform and set a new price target of $11.00

    12/4/25 1:31:31 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cross Country Healthcare and Open Hearts for Orphans Announce Community Partnership to Strengthen Families and Support Vulnerable Children

    Cross Country Healthcare, Inc. (NASDAQ:CCRN), a technology-driven healthcare workforce solutions company delivering an AI-powered digital platform and advisory services backed by nearly 40 years of healthcare labor expertise, today announced a new community partnership with Open Hearts for Orphans (OHFO), a South Florida nonprofit dedicated to providing hope, healing, and family for orphaned and vulnerable children. This partnership brings together two mission-driven organizations committed to strengthening families, supporting communities, and improving outcomes for vulnerable children and the caregivers who support them. Through this collaboration, Cross Country will support OHFO thro

    3/10/26 7:30:00 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country Healthcare Announces Fourth Quarter and Full Year 2025 Financial Results

    Cross Country Healthcare, Inc. (the "Company," "Cross Country," "we," "us," and "our") (NASDAQ:CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2025. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2025 Variance Q4 2025 vs Q4 2024 Variance Q4 2025 vs Q3 2025 Full Year 2025 Variance 2025 vs 2024 Revenue $ 236,761       (24 ) %   (5 ) % $ 1,054,293       (22 ) % Gross profit margin*   20.3   %   30

    3/4/26 4:15:00 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country Healthcare to Attend the Truist Securities Virtual Human Capital Conference and the Oppenheimer 36th Annual Healthcare Medtech & Services Conference

    Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in two upcoming conferences: The Truist Securities Virtual Human Capital Conference taking place March 12-13, 2026, with one-on-one investor meetings on Thursday, March 12. The Oppenheimer 36th Annual Healthcare MedTech & Services Conference taking place March 16-19, 2026, with one-on-one investor meetings on Tuesday, March 17. In attendance and participating in one-on-ones at both conferences will be William J. Burns, Executive Vice President & Chief Financial Officer and Josh Vogel, Vice President, Investor Relations. No formal presentation will be made at either confe

    2/23/26 4:15:00 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    SEC Filings

    View All

    Cross Country Healthcare Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)

    3/10/26 4:12:04 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    SEC Form 10-K filed by Cross Country Healthcare Inc.

    10-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)

    3/9/26 6:25:36 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)

    3/4/26 4:27:33 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cash W Larry bought $40,829 worth of shares (5,000 units at $8.17), increasing direct ownership by 3% to 204,632 units (SEC Form 4)

    4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

    12/9/25 4:08:59 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Director Cash W Larry bought $61,320 worth of shares (6,000 units at $10.22), increasing direct ownership by 3% to 199,632 units (SEC Form 4)

    4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

    12/31/24 5:15:10 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cross Country Healthcare Inc.

    SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

    11/13/24 9:39:57 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Cross Country Healthcare Inc.

    SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

    11/13/24 4:36:10 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    SEC Form SC 13G/A filed by Cross Country Healthcare Inc. (Amendment)

    SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

    2/13/24 5:02:31 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Financials

    Live finance-specific insights

    View All

    Cross Country Healthcare Announces Fourth Quarter and Full Year 2025 Financial Results

    Cross Country Healthcare, Inc. (the "Company," "Cross Country," "we," "us," and "our") (NASDAQ:CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2025. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2025 Variance Q4 2025 vs Q4 2024 Variance Q4 2025 vs Q3 2025 Full Year 2025 Variance 2025 vs 2024 Revenue $ 236,761       (24 ) %   (5 ) % $ 1,054,293       (22 ) % Gross profit margin*   20.3   %   30

    3/4/26 4:15:00 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Wednesday, March 4, 2026

    Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Wednesday, March 4, 2026 at 5:00 P.M. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, March 4, 2026. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 800-369-2163 from anywhere in the U.S. or by dialing 773-756-4715 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from March 4th through March 18th on the Company's website and a replay of

    2/12/26 4:15:00 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country Healthcare Announces Third Quarter 2025 Financial Results

    Cross Country Healthcare, Inc. (the Company) (NASDAQ:CCRN) today announced financial results for its third quarter ended September 30, 2025. Selected Financial Information:     Variance Variance     Q3 2025 vs Q3 2025 vs Dollars are in thousands, except per share amounts Q3 2025 Q3 2024 Q2 2025 Revenue $ 250,052     (21 )%   (9 )% Gross profit margin*   20.4 %   — bps   — bps Net loss attributable to common stockholders $ (4,774 )   (287 )%

    11/12/25 4:56:00 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Leadership Updates

    Live Leadership Updates

    View All

    Cross Country Healthcare Announces CEO Transition

    Co-Founder and Chairman, Kevin C. Clark, Returns as Chief Executive Officer Cross Country Healthcare, Inc. (the "Company" and "Cross Country") (NASDAQ:CCRN) today announced that John A. Martins, the Company's President and Chief Executive Officer, has separated from the Company and ceased to serve as a member of its Board of Directors (the "Board"), effective as of December 14, 2025. The Board appointed Kevin C. Clark, the Company's current Chairman, former Chief Executive Officer, and Co-Founder, to succeed Mr. Martins as the Company's President and Chief Executive Officer. Mr. Clark will continue to serve as the Chairman of the Board. "The Board members are thrilled to have Kevin return

    12/15/25 8:15:00 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash

    Cross Country stockholders to receive $18.61 per share Expands Aya's client service and delivery capabilities with Cross Country's nearly 40-year history of clinical excellence and quality patient care Provides clinicians with greater flexibility and convenience by tapping into the combined pool of nationwide opportunities, with competitive compensation and a world-class experience Creates immediate stockholder value for Cross Country, through a nearly 67 percent premium Aya Healthcare and Cross Country Healthcare today announced that they have entered into a definitive agreement whereby Aya will acquire Cross Country for $18.61 per share in cash in a transaction valued at appr

    12/4/24 7:45:00 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    The Ensign Group Set to Join S&P MidCap 400; Curbline Properties & TransMedics Group to Join S&P SmallCap 600

    NEW YORK, Sept. 26, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 and S&P MidCap 400: S&P SmallCap 600 constituent The Ensign Group Inc. (NASD: ENSG) will replace Southwestern Energy Co. (NYSE:SWN) in the S&P MidCap 400 and TransMedics Group, Inc. (NASD: TMDX) will replace The Ensign Group in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 1.  S&P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.Curbline Properties Corp. (NYSE:CURB) will be added to the S&P SmallCap 600 effective prior to the open of trading on Tuesda

    9/26/24 6:04:00 PM ET
    $CCRN
    $CHK
    $ENSG
    Professional Services
    Consumer Discretionary
    Oil & Gas Production
    Energy